Literature DB >> 1977979

Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations.

A H Cromme-Dijkhuis1, C M Henkens, C M Bijleveld, H L Hillege, V J Bom, J van der Meer.   

Abstract

Severe thromboembolism occurred in 3 of 37 patients who had undergone Fontan-type operations for correction of congenital heart defects several months to years after the operation. The patients were screened for coagulation factor abnormalities to find out whether known prothrombotic risk factors could explain the high frequency of thromboembolism. 63 abnormalities were found in 24 of the 37 patients. The commonest and most pronounced abnormality was deficiency of protein C, a known risk factor. Concentrations of antithrombin III and factors II and X were significantly lower in protein-C-deficient patients than in those with normal protein C concentrations. These findings suggest that the high thrombotic risk in these patients is caused or at least associated with an imbalance between procoagulant and anticoagulant factors.

Entities:  

Mesh:

Year:  1990        PMID: 1977979     DOI: 10.1016/0140-6736(90)92568-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function.

Authors:  R Kaulitz; I Luhmer; F Bergmann; B Rodeck; G Hausdorf
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

2.  Prophylactic anticoagulation following the Fontan operation.

Authors:  H A Walker; M A Gatzoulis
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

3.  Factors associated with stroke following the Fontan procedure.

Authors:  R W Day; R S Boyer; V F Tait; H D Ruttenberg
Journal:  Pediatr Cardiol       Date:  1995 Nov-Dec       Impact factor: 1.655

4.  Successful thrombolytic therapy for acute massive pulmonary thrombosis after total cavo-pulmonary shunt.

Authors:  Katsuhide Maeda; Arata Murakami; Toshio Hishi; Shinichi Takamoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-10

Review 5.  Thromboembolism and the role of anticoagulation in the Fontan patient.

Authors:  M L Jacobs; K K Pourmoghadam
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

6.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

7.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

8.  Thromboelastography of patients after fontan compared with healthy children.

Authors:  Leslie Raffini; Alexander Schwed; X Long Zheng; Maria Tanzer; Susan Nicolson; J William Gaynor; David Jobes
Journal:  Pediatr Cardiol       Date:  2009-04-09       Impact factor: 1.655

9.  Oral anticoagulation in paediatric patients: dose requirements and complications.

Authors:  R C Tait; E J Ladusans; M El-Metaal; R G Patel; A M Will
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

10.  Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure.

Authors:  C B Mahnke; G J Boyle; J E Janosky; R D Siewers; F A Pigula
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.